
Press Release|Articles|April 14, 2025
Camber Pharmaceuticals Launches Lurasidone Hydrochloride Tablets
Advertisement
Camber Pharmaceuticals is excited to announce the addition of Lurasidone Hydrochloride Tablets.
Lurasidone Hydrochloride Tablets are an atypical antipsychotic indicated for the treatment of:
- Schizophrenia in adults and adolescents (13 to 17 years)
- Depressive episode associated with Bipolar I Disorder (bipolar depression) in adults and pediatric patients (10 to 17 years) as monotherapy
- Depressive episode associated with Bipolar I Disorder (bipolar depression) in adults as adjunctive therapy with lithium or valproate
Lurasidone Hydrochloride Tablets in 20 mg, 40 mg, 60 mg, 80 mg, 120 mg strengths are available in 30-count bottles.
To find out more information on Lurasidone Hydrochloride Tablets, please visit:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
FDA Initiates Approval of Leucovorin for Patients With Cerebral Folate Deficiency
2
Rapid CAR T Expansion Linked to Delayed Neurotoxicity in Patients Treated With Cilta-Cel
3
Hercessi, Biosimilar to Herceptin, Shows Favorable Efficacy, Safety in Treating HER2+ MBC in Real-World Setting
4
IMS: Shaping the Future of Multiple Myeloma with Anti-CD38 Quadruplets
5